Back to Search

JUSTINNE GUYTON, PHARMD

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

NPI: 1487924973Individual

Specialties, Licenses & Credentials

Pharmacist Clinician (PhC)/ Clinical Pharmacy SpecialistPrimary

Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

Code: 1835P0018X

E-11846(MS)22637(NC)

Research & Publications (20)

Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
PMID 10789612·Arch Intern Med·2000
3-trial
Total knee arthroplasty with asymmetric femoral condyles and tibial tray.
PMID 19150215·J Arthroplasty·2010
8-other
Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia.
PMID 19508464·Diabetes Obes Metab·2009
4-observational
The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.
PMID 18721512·Am J Cardiol·2008
8-other
Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
PMID 18420099·J Am Coll Cardiol·2008
4-observational
Niacin in cardiovascular prevention: mechanisms, efficacy, and safety.
PMID 17620858·Curr Opin Lipidol·2007
6-review
Safety considerations with niacin therapy.
PMID 17368274·Am J Cardiol·2007
6-review
Safety considerations with gastrointestinally active lipid-lowering drugs.
PMID 17368279·Am J Cardiol·2007
8-other
Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury.
PMID 17521631·Exp Neurol·2007
7-preclinical
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.
PMID 16675728·Stroke·2006
6-review
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group.
PMID 16785347·Circulation·2006
6-review
Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.
PMID 17165637·Mayo Clin Proc·2006
4-observational
Effect of a low-carbohydrate, ketogenic diet program compared to a low-fat diet on fasting lipoprotein subclasses.
PMID 16297472·Int J Cardiol·2006
3-trial
Statin safety: an assessment using an administrative claims database.
PMID 16581331·Am J Cardiol·2006
8-other
Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.
PMID 16581336·Am J Cardiol·2006
6-review
Benefit versus risk in statin treatment.
PMID 16581337·Am J Cardiol·2006
8-other
Metabolic syndrome: evaluation of pathological and therapeutic outcomes.
PMID 15660031·Am Heart J·2005
8-other
Metabolic syndrome: definition, pathophysiology, and mechanisms.
PMID 15660032·Am Heart J·2005
8-other
Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?
PMID 14715339·Am J Cardiol·2004
3-trial
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
PMID 15374793·Am J Cardiol·2004
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
101 MANNING DR, DEPARTMENT OF PHARMACY, CB 7600
CHAPEL HILL, NC 27514

Location

Practice Location

101 MANNING DR, CHAPEL HILL, NC
(314) 537-1598

Quick Facts

NPI
1487924973
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile